BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malagelada J. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation: DIAGNOSIS OF IBS-C. International Journal of Clinical Practice 2006;60:57-63. [DOI: 10.1111/j.1368-5031.2005.00744.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Jones R, Rubin G. A positive diagnosis in irritable bowel syndrome: LETTERS. International Journal of Clinical Practice 2006;60:870-870. [DOI: 10.1111/j.1368-5031.2006.0919a.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Rivkin A, Chagan L. Lubiprostone: chloride channel activator for chronic constipation. Clin Ther 2006;28:2008-21. [PMID: 17296458 DOI: 10.1016/j.clinthera.2006.12.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
3 Quigley EM, Bytzer P, Jones R, Mearin F. Irritable bowel syndrome: The burden and unmet needs in Europe. Dig Liver Dis. 2006;38:717-723. [PMID: 16807154 DOI: 10.1016/j.dld.2006.05.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 4.0] [Reference Citation Analysis]
4 Layer P, Keller J, Loeffler H, Kreiss A. Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom. Ther Clin Risk Manag 2007;3:107-18. [PMID: 18360619 DOI: 10.2147/tcrm.2007.3.1.107] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
5 Rehman NU, Ansari MN, Samad A. In Silico, Ex Vivo and In Vivo Studies of Roflumilast as a Potential Antidiarrheal and Antispasmodic agent: Inhibition of the PDE-4 Enzyme and Voltage-gated Ca++ ion Channels. Molecules 2020;25:E1008. [PMID: 32102361 DOI: 10.3390/molecules25041008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Collins SM. Translating symptoms into mechanisms: functional GI disorders. Adv Physiol Educ. 2007;31:329-331. [PMID: 18057404 DOI: 10.1152/advan.00058.2007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
7 Jellema P, van der Windt DA, Schellevis FG, van der Horst HE. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther. 2009;30:695-706. [PMID: 19575763 DOI: 10.1111/j.1365-2036.2009.04087.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
8 Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol 2015; 21(10): 3072-3084 [PMID: 25780308 DOI: 10.3748/wjg.v21.i10.3072] [Cited by in CrossRef: 160] [Cited by in F6Publishing: 125] [Article Influence: 22.9] [Reference Citation Analysis]
9 Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int. 2015;2015:505878. [PMID: 25793197 DOI: 10.1155/2015/505878] [Cited by in Crossref: 150] [Cited by in F6Publishing: 140] [Article Influence: 21.4] [Reference Citation Analysis]
10 Lin S, Mooney PD, Kurien M, Aziz I, Leeds JS, Sanders DS. Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes. European Journal of Gastroenterology & Hepatology 2014;26:1176-80. [DOI: 10.1097/meg.0000000000000171] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
11 Tang QL, Lin GY, Zhang MQ. Cognitive-behavioral therapy for the management of irritable bowel syndrome. World J Gastroenterol 2013; 19(46): 8605-8610 [PMID: 24379577 DOI: 10.3748/wjg.v19.i46.8605] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
12 Coffin B. [Diagnosis of irritable bowel syndrome]. Gastroenterol Clin Biol 2009;33 Suppl 1:S9-16. [PMID: 19303544 DOI: 10.1016/S0399-8320(09)71520-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
13 Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009;18:349-358. [PMID: 19243285 DOI: 10.1517/13543780902780175] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
14 Elhosseiny D, Mahmoud NE, Manzour AF. Factors associated with irritable bowel syndrome among medical students at Ain Shams University. J Egypt Public Health Assoc 2019;94:23. [PMID: 32813140 DOI: 10.1186/s42506-019-0023-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Chogle A, Dhroove G, Sztainberg M, Di Lorenzo C, Saps M. How reliable are the Rome III criteria for the assessment of functional gastrointestinal disorders in children? Am J Gastroenterol. 2010;105:2697-2701. [PMID: 20808296 DOI: 10.1038/ajg.2010.350] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
16 Al-Hazmi AH. Knowledge, attitudes, and practices of primary care physicians about irritable bowel syndrome in Northern Saudi Arabia. Saudi J Gastroenterol 2012;18:173-81. [PMID: 22626796 DOI: 10.4103/1319-3767.96450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
17 Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Jonsson JS, Bjornsson E, Thjodleifsson B. Irritable bowel syndrome: Physicians' awareness and patients' experience. World J Gastroenterol 2012; 18(28): 3715-3720 [PMID: 22851864 DOI: 10.3748/wjg.v18.i28.3715] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
18 Halland M, Talley NJ. New treatments for IBS. Nat Rev Gastroenterol Hepatol. 2013;10:13-23. [PMID: 23147658 DOI: 10.1038/nrgastro.2012.207] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
19 Jasper F, Egloff B, Roalfe A, Witthöft M. Latent structure of irritable bowel syndrome symptom severity. World J Gastroenterol 2015; 21(1): 292-300 [PMID: 25574104 DOI: 10.3748/wjg.v21.i1.292] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
20 Basu PP, Shah NJ, Krishnaswamy N, Pacana T. Prevalence of restless legs syndrome in patients with irritable bowel syndrome. World J Gastroenterol 2011; 17(39): 4404-4407 [PMID: 22110266 DOI: 10.3748/wjg.v17.i39.4404] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
21 Hatton GB, Madla CM, Rabbie SC, Basit AW. All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance. Int J Pharm 2018;548:408-22. [PMID: 29969711 DOI: 10.1016/j.ijpharm.2018.06.054] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
22 Novak KL, Jacob D, Kaplan GG, Boyce E, Ghosh S, Ma I, Lu C, Wilson S, Panaccione R. Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea. Can J Gastroenterol Hepatol. 2016;2016:4023065. [PMID: 27446838 DOI: 10.1155/2016/4023065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
23 Eskander EF, Abd-Rabou AA, Ahmed HH. The impact of digestive and colon drugs on the human hormones profile. Indian J Clin Biochem 2013;28:413-7. [PMID: 24426246 DOI: 10.1007/s12291-013-0311-6] [Reference Citation Analysis]